Matches in Wikidata for { <http://www.wikidata.org/entity/Q91751022> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q91751022 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91751022 description "scientific article published on 17 February 2019" @default.
- Q91751022 description "wetenschappelijk artikel" @default.
- Q91751022 description "наукова стаття, опублікована в лютому 2019" @default.
- Q91751022 name "Cholinergic drugs ameliorate endothelial dysfunction by decreasing O-GlcNAcylation via M3 AChR-AMPK-ER stress signaling" @default.
- Q91751022 name "Cholinergic drugs ameliorate endothelial dysfunction by decreasing O-GlcNAcylation via M3 AChR-AMPK-ER stress signaling" @default.
- Q91751022 type Item @default.
- Q91751022 label "Cholinergic drugs ameliorate endothelial dysfunction by decreasing O-GlcNAcylation via M3 AChR-AMPK-ER stress signaling" @default.
- Q91751022 label "Cholinergic drugs ameliorate endothelial dysfunction by decreasing O-GlcNAcylation via M3 AChR-AMPK-ER stress signaling" @default.
- Q91751022 prefLabel "Cholinergic drugs ameliorate endothelial dysfunction by decreasing O-GlcNAcylation via M3 AChR-AMPK-ER stress signaling" @default.
- Q91751022 prefLabel "Cholinergic drugs ameliorate endothelial dysfunction by decreasing O-GlcNAcylation via M3 AChR-AMPK-ER stress signaling" @default.
- Q91751022 P1104 Q91751022-CED13DE0-2923-40F3-827A-5818E86007B5 @default.
- Q91751022 P1433 Q91751022-44F8426E-2394-4CD5-BED6-C3A24B14987C @default.
- Q91751022 P1476 Q91751022-ECE85C99-D8C8-4A28-A016-AB029772E3FC @default.
- Q91751022 P2093 Q91751022-1BDFCC66-9112-4372-B1E1-7624DCE43288 @default.
- Q91751022 P2093 Q91751022-48C0D7AB-2BB9-443B-ACF6-747F687529A3 @default.
- Q91751022 P2093 Q91751022-5C46D30E-0E0A-47FA-97A6-7CEFC60698F8 @default.
- Q91751022 P2093 Q91751022-5E096A1F-971D-4EE3-8DA1-7FB2D90CDDCE @default.
- Q91751022 P2093 Q91751022-AF114D49-6552-448F-AF41-B6BB9DD2EB4B @default.
- Q91751022 P2093 Q91751022-C4A010AB-3612-491F-8F51-9150BB98A8A7 @default.
- Q91751022 P2093 Q91751022-C9607C15-1286-4A04-8FF2-7E16FFEA7DE9 @default.
- Q91751022 P2093 Q91751022-D44B08D6-1E5E-4DF3-B389-057297FADCD0 @default.
- Q91751022 P2093 Q91751022-E9A930F1-2649-4EFE-94FF-6BCE6D348819 @default.
- Q91751022 P2093 Q91751022-F48A74B6-9739-44A2-8F68-3E45FAACD5C9 @default.
- Q91751022 P2860 Q91751022-6091E16F-8B5B-4B17-9547-01C3472EBB29 @default.
- Q91751022 P304 Q91751022-588FA544-0DCE-4500-B478-2FFC95605C71 @default.
- Q91751022 P31 Q91751022-788A27BF-B651-417A-A9D2-B7D4AAF5EA39 @default.
- Q91751022 P356 Q91751022-239EA9F9-DE30-4B56-8A3F-D61BB40DA321 @default.
- Q91751022 P478 Q91751022-A6831FFF-48D6-4FC9-A6D0-B7A374FBDA82 @default.
- Q91751022 P577 Q91751022-0EF2905D-E955-4846-81F1-66C010C373B6 @default.
- Q91751022 P698 Q91751022-B4B1E7B2-8579-419C-9262-E0E820AAE580 @default.
- Q91751022 P356 J.LFS.2019.02.036 @default.
- Q91751022 P698 30786250 @default.
- Q91751022 P1104 "+12" @default.
- Q91751022 P1433 Q5256275 @default.
- Q91751022 P1476 "Cholinergic drugs ameliorate endothelial dysfunction by decreasing O-GlcNAcylation via M3 AChR-AMPK-ER stress signaling" @default.
- Q91751022 P2093 "Dong-Ling Li" @default.
- Q91751022 P2093 "Long-Zhu Liu" @default.
- Q91751022 P2093 "Ming Zhao" @default.
- Q91751022 P2093 "Qing Wu" @default.
- Q91751022 P2093 "Run-Qing Xue" @default.
- Q91751022 P2093 "Si Yang" @default.
- Q91751022 P2093 "Wei-Jin Zang" @default.
- Q91751022 P2093 "Xi He" @default.
- Q91751022 P2093 "Xiao-Jiang Yu" @default.
- Q91751022 P2093 "Yan-Ling Cui" @default.
- Q91751022 P2860 Q35894298 @default.
- Q91751022 P304 "1-12" @default.
- Q91751022 P31 Q13442814 @default.
- Q91751022 P356 "10.1016/J.LFS.2019.02.036" @default.
- Q91751022 P478 "222" @default.
- Q91751022 P577 "2019-02-17T00:00:00Z" @default.
- Q91751022 P698 "30786250" @default.